IP Library Granted Patent US 7,960,502
Granted Patent B2
US 7,960,502 · App. 12/689,979 · Granted Jun 14, 2011

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,502
App. No.
12/689,979
Granted
Jun 14, 2011
Kind
B2
Abstract

The invention provides a sterically hindered polymer that comprises a water-soluble and non-peptidic polymer backbone having at least one terminus covalently bonded to an alkanoic acid or alkanoic acid derivative, wherein the carbon adjacent to the carbonyl group of the acid or acid derivative group has an alkyl or aryl group pendent thereto. The steric effects of the alkyl or aryl group allow greater control of the hydrolytic stability of polymer derivatives. The polymer backbone may be poly(ethylene glycol).

Claims (21)

1. A method comprising precipitating a polymer having the structure:

wherein:

R is a central core molecule;

POLY is a water-soluble and non-peptidic polymer backbone;

Q is O or S;

m is 1 to about 20;

Z is selected from the group consisting of alkyl, substituted alkyl, aryl and substituted aryl; and

X is a leaving group; and

q is an integer from 2 to about 300; and

wherein said precipitating is effected by use of a solvent in which the polymer is essentially insoluble.

2. The method of claim 1 , wherein R is glycerol residue.

3. The method of claim 1 , wherein R is a pentaerythritol residue.

4. The method of claim 1 , wherein q is 8.

5. The method of claim 1 , wherein POLY is poly(ethylene glycol).

6. The method of claim 5 , wherein the poly(ethylene glycol) has an average molecular weight from about 200 Da to about 100,000 Da.

7. The method of claim 1 , wherein Z is a C 1 -C 8 alkyl or substituted alkyl.

8. The method of claim 1 , wherein Z is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, and benzyl.

9. The method of claim 1 , wherein m is 1 to about 10.

10. The method of claim 1 , wherein X is hydroxyl.

11. The method of claim 1 , wherein the solvent is ethyl ether.

12. The method of claim 1 , wherein the solvent is isopropranol.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →